Login

Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
ASSETS
CURRENT ASSETS:
Cash
Franchise tax receivable
Prepaid expenses and other assets
Total current assets
Deferred offering costs
Prepaid expenses and other assets, net of current portion
Cash held in Trust Account
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS' DEFICIT
CURRENT LIABILITIES:
Accounts payable
Accrued expenses
Sponsor loan
Income tax payable
Excise tax payable
Franchise tax payable
Forward purchase liabilities
Total current liabilities
Promissory note - related party
Derivative warrant liabilities
Deferred underwriting fee payable
TOTAL LIABILITIES
Class A common stock, $0.0001 par value; 200,000,000 shares authorized; 1,065,468 at $10.53 and 27,510,000 at $10.13 redemption value issued and outstanding as of December 31, 2023 and 2022, respectively, subject to possible redemption
Stockholders' deficit:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; 1,000,000 shares issued and outstanding at December 31, 2023. No shares were issued and outstanding as of December 31, 2022
Common stock, value
Common Class B
Non redeemable ClassA commonstock
Total common stock, value
Additional paid-in capital
Accumulated deficit
Total stockholders' deficit
TOTAL LIABILITIES, COMMON STOCK AND STOCKHOLDERS' DEFICIT

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support